Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
CALL
The Mosaic Company
MOS
$6.95B
| $99K | ﹤0.01% |
3,100
-29,500
| -90% | -$1M |
|
|
FBMS
3802
DELISTED
The First Bancshares, Inc.
FBMS
| $99K | ﹤0.01% |
2,636
-14,421
| -85% | -$556K |
|
3803
Silicon Laboratories
SLAB
$7.19B
| $98K | ﹤0.01% |
634
-87,103
| -99% | -$12.2M |
|
3804
AnaptysBio
ANAB
$1.58B
| $97K | ﹤0.01% |
3,725
-14,174
| -79% | -$340K |
|
3805
Horizon Bancorp
HBNC
$1.06B
| $97K | ﹤0.01% |
5,528
-30,225
| -85% | -$551K |
|
3806
LCNB Corp
LCNB
$284M
| $97K | ﹤0.01% |
5,956
-4,212
| -41% | -$73.9K |
|
|
MESO
3807
Mesoblast
MESO
$1.85B
| $97K | ﹤0.01% |
6,500
+6,050
| +1,344% | +$95K |
|
|
MILN
3808
Global X Millennial Consumer ETF
MILN
$102M
| $97K | ﹤0.01% |
2,250
| – | – |
|
3809
Ribbon Communications
RBBN
$375M
| $97K | ﹤0.01% |
12,645
-45,092
| -78% | -$345K |
|
|
DS
3810
DELISTED
Drive Shack Inc.
DS
| $97K | ﹤0.01% |
+29,467
| New | +$94.3K |
|
3811
iShare MSCI Eurozone ETF
EZU
$9.71B
| $96K | ﹤0.01% |
1,941
-3
| -0.2% | -$149 |
|
|
RTLR
3812
DELISTED
Rattler Midstream LP Common Units
RTLR
| $96K | ﹤0.01% |
8,771
-1,800
| -17% | -$19.8K |
|
|
ATRS
3813
DELISTED
Antares Pharma, Inc.
ATRS
| $96K | ﹤0.01% |
21,731
-166,206
| -88% | -$677K |
|
3814
Ares Capital
ARCC
$13.7B
| $95K | ﹤0.01% |
4,821
-1,174
| -20% | -$22.7K |
|
3815
PUT
BHP
BHP
$212B
| $95K | ﹤0.01% |
1,457
| – | – |
|
3816
Caledonia Mining Corp
CMCL
$362M
| $95K | ﹤0.01% |
7,845
-6,997
| -47% | -$98.4K |
|
3817
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.39B
| $95K | ﹤0.01% |
1,015
+917
| +936% | +$85.3K |
|
3818
Mistras Group
MG
$492M
| $95K | ﹤0.01% |
9,704
-12,607
| -57% | -$136K |
|
3819
Ooma
OOMA
$597M
| $95K | ﹤0.01% |
5,035
-12,818
| -72% | -$232K |
|
3820
CALL
ProShares UltraShort S&P500
SDS
$408M
| $95K | ﹤0.01% |
420
| – | – |
|
3821
TransAlta
TAC
$3.92B
| $95K | ﹤0.01% |
9,564
+9,464
| +9,464% | +$91.4K |
|
|
SP
3822
DELISTED
SP Plus Corporation
SP
| $95K | ﹤0.01% |
3,137
-16,710
| -84% | -$547K |
|
3823
Hyster-Yale Materials Handling
HY
$619M
| $94K | ﹤0.01% |
1,284
-6,996
| -84% | -$543K |
|
3824
The RMR Group
RMR
$326M
| $94K | ﹤0.01% |
2,458
-10,254
| -81% | -$409K |
|
3825
FRP Holdings
FRPH
$437M
| $93K | ﹤0.01% |
3,362
-7,482
| -69% | -$207K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.